BridgeBio Pharma (BBIO) wins FDA nod Attruby for rare heart disorder, ATTR-CM challenging Pfizer's (PFE) Vyndaqel. Read more ...
A research team at the University of Vienna, led by medicinal chemist Markus Muttenthaler, has developed a new class of oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback